1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Consumption 2015-2025
2.1.2 Influenza Vaccine Consumption CAGR by Region
2.2 Influenza Vaccine Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Influenza Vaccine Consumption by Type
2.3.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Vaccine Sale Price by Type (2015-2020)
2.4 Influenza Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Influenza Vaccine Consumption by Application
2.5.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Vaccine Sale Price by Type (2015-2020)
3 Global Influenza Vaccine by Company
3.1 Global Influenza Vaccine Sales Market Share by Company
3.1.1 Global Influenza Vaccine Sales by Company (2018-2020)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Influenza Vaccine Revenue Market Share by Company
3.2.1 Global Influenza Vaccine Revenue by Company (2018-2020)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Global Influenza Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Influenza Vaccine by Regions
4.1 Influenza Vaccine by Regions
4.2 Americas Influenza Vaccine Consumption Growth
4.3 APAC Influenza Vaccine Consumption Growth
4.4 Europe Influenza Vaccine Consumption Growth
4.5 Middle East & Africa Influenza Vaccine Consumption Growth
5 Americas
5.1 Americas Influenza Vaccine Consumption by Countries
5.1.1 Americas Influenza Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Vaccine Value by Countries (2015-2020)
5.2 Americas Influenza Vaccine Consumption by Type
5.3 Americas Influenza Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Vaccine Consumption by Regions
6.1.1 APAC Influenza Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Vaccine Value by Regions (2015-2020)
6.2 APAC Influenza Vaccine Consumption by Type
6.3 APAC Influenza Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Influenza Vaccine by Countries
7.1.1 Europe Influenza Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Vaccine Value by Countries (2015-2020)
7.2 Europe Influenza Vaccine Consumption by Type
7.3 Europe Influenza Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccine by Countries
8.1.1 Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Vaccine Consumption by Type
8.3 Middle East & Africa Influenza Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccine Distributors
10.3 Influenza Vaccine Customer
11 Global Influenza Vaccine Market Forecast
11.1 Global Influenza Vaccine Consumption Forecast (2021-2025)
11.2 Global Influenza Vaccine Forecast by Regions
11.2.1 Global Influenza Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Influenza Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Vaccine Forecast by Type
11.8 Global Influenza Vaccine Forecast by Application
12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Influenza Vaccine Product Offered
12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Influenza Vaccine Product Offered
12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Influenza Vaccine Product Offered
12.3.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 AstraZeneca
12.4.1 Company Information
12.4.2 Influenza Vaccine Product Offered
12.4.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 AstraZeneca Latest Developments
12.5 Sanofi Pasteur
12.5.1 Company Information
12.5.2 Influenza Vaccine Product Offered
12.5.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Pasteur Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Influenza Vaccine Product Offered
12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Johnson & Johnson
12.7.1 Company Information
12.7.2 Influenza Vaccine Product Offered
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Johnson & Johnson Latest Developments
…
13 Research Findings and Conclusion
【免責事項】
https://www.globalresearch.jp/disclaimer